Feedback / Questions
ABP-102 - Celltrion
https://www.globenewswire.com/news-release/2025/12/15/3205290/0/en/Abpro-Holdings-Announces-Submission-of-an-IND-Application-to-Initiate-a-Phase-1-Clinical-Trial-of-T-cell-engager-ABP-102-CT-P72-for-HER2-positive-Cancers.html
Dec 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next